Study for Autologous Blood-Derived Fibrin Gel (CGF) in Root-end Resectio

Not Applicable

Recruiting

• Conditions: Apical periodontitis

• Registration Number: JPRN-UMIN000035878
• Lead Sponsor: Japanese Association for Dental Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-02-15
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with malignant tumor complicated or having a history 2. Patients with abnormal gingival proliferation or having a history of abnormal gingival proliferation 3. Malignant tumor, premalignant lesion or finding that they are suspected by intraoral diagnosis 4. Patients under 20 or over 70 5. Other patients who are suffering from severe infectious diseases etc. Patients who are judged to be inappropriate for dental practitioners providing this regenerative medicine, etc. from the viewpoint of safety measures etc. to the person who manufactures the following items Consider taking the interview and examination. (A) Hepatitis B virus (HBV) (B) Hepatitis C virus (HCV) (C) Human immunodeficiency virus (HIV) (D) Human T cell leukemia virus type 1 (HTLV-1)

Study & Design

• Study Type: Interventional
• Study Design: Not specified